Parents Need To Know More About Study Drug Use In Teens
[ Watch the Video: One in Ten Teens Using Study Drugs ] Brett Smith for redOrbit.com - Your Universe Online While the signs and dangers of recreational drug use such as painkillers or LSD are well-known to teens and their parents, a new...
Latest Adderall Stories
Just one in 100 parents believe their kids have used prescription stimulants to boost grades, according to new U-M National Poll on Children's Health ANN ARBOR, Mich., May 20, 2013 /PRNewswire-USNewswire/ -- As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug" - a prescription stimulant or amphetamine - to gain an academic edge. But a new University of Michigan poll shows only one in 100 parents of teens 13-17 years old believes that...
April Flowers for redOrbit.com - Your Universe Online A new study from the Ann Arbor Veterans Health Administration (VA) Healthcare System and the University of Michigan reveals the US Food and Drug Administration’s (FDA) warning that high doses of citalopram, also known as Celexa, can cause potentially serious abnormal heart rhythms might be doing more harm than good. The FDA attached a warning to the antidepressant in 2011, based on data linking higher doses of the drug to...
Mental health professionals at the Birmingham Maple Clinic recently reported on a study by the Partnership at Drugfree.org, which found that prescription drug abuse among teens has risen 33% since 2008. Troy, MI (PRWEB) May 02, 2013 Michigan mental health professionals at the Birmingham Maple Clinic recently reported on a study by the Partnership at Drugfree.org, which found that prescription drug abuse among teens has risen 33% since 2008. Lori Edelson, Birmingham Maple Clinic therapist...
Brett Smith for redOrbit.com - Your Universe Online Misuse of a commonly-prescribed ADHD medication isn’t just trendy amongst college students hoping to gain an academic advantage during finals time, it’s also trending on Twitter, new research has discovered. Adderall, a psychostimulant medication that contains amphetamine, is being used by an increasing number of post-secondary students as they take their final exams – and those individuals aren’t shying away from posting about...
PHILADELPHIA, April 25, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that its subsidiary, Shire LLC, has settled all pending litigation with Actavis, Inc., Actavis LLC, and Actavis Elizabeth LLC (collectively "Actavis") and Watson Laboratories, Inc.-Florida, Watson Pharma, Inc. and ANDA, Inc. (collectively "Watson") in connection with Actavis' and Watson's Abbreviated New Drug Applications ("ANDAs") for generic versions of Shire's INTUNIV(R) ( guanfacine...
Parents' Lax Attitudes and Behavior Linked to Teen Rx Drug Misuse and Abuse Nearly One-Third of Parents Believe Stimulants Can Improve Academic Performance, Even for Teens Who Do Not Have Attention Deficit Hyperactivity Disorder NEW YORK, April 23, 2013 /PRNewswire-USNewswire/ -- New, nationally projectable survey results released today by The Partnership at Drugfree.org and MetLife Foundation confirmed that one in four teens has misused or abused a prescription (Rx) drug at least...
Acquisition brings Shire a new phase 3 compound being investigated for the signs and symptoms of Dry Eye Disease LEXINGTON, Massachusetts, March 25, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it will acquire SARcode Bioscience Inc., a privately held biopharmaceutical company based in Brisbane, California. This acquisition continues to build Shire's presence in the ophthalmology therapeutic category and brings a new phase 3 compound -...
Deal Enhances Shire's Late-Stage Pipeline with the Acquisition of a Phase II Protein Replacement Therapy Being Investigated for the Prevention of Retinopathy of Prematurity LEXINGTON, Massachusetts, March 12, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that it has acquired Premacure AB of Uppsala, Sweden, a privately held biotechnology company developing a protein replacement therapy, currently in Phase II development, for the prevention of retinopathy...
A New Direction for Men and Women Who Want to Improve Memory and Focus. HOUSTON, March 6, 2013 /PRNewswire-iReach/ -- It's a classic situation - you meet someone new, and then moments later you've forgotten their name! Names, passwords, pin and telephone numbers... the list is endless - with so much to memorize is it really possible to improve how much you can remember? (Photo: http://photos.prnewswire.com/prnh/20130306/CG71794) The good news is, yes! Just like every muscle in...
LEXINGTON, Massachusetts, February 28, 2013 /PRNewswire/ -- - Global Initiatives Underscore Company's Long-Term Commitment to the Rare Disease Community Shire plc (LSE: SHP, NASDAQ: SHPG) today announced its support of Rare Disease Day, joining patients, healthcare providers, and patient organizations around the world to support a day that focuses attention on rare diseases as a public health issue, and highlights the need for more understanding and awareness about...

